fluocinolone implant Iluvien
Selected indexed studies
- Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review. (J Int Med Res, 2019) [PMID:30556449]
- Intravitreal Fluocinolone Acetonide Implant (ILUVIEN(®)) for the Treatment of Retinal Conditions. A Review of Clinical Studies. (Drug Des Devel Ther, 2023) [PMID:37020801]
- Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN(®)): A Review in Diabetic Macular Edema. (Drugs, 2017) [PMID:28283896]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN(®)): A Review in Diabetic Macular Edema. (2017) pubmed
- Fluocinolone acetonide intravitreal implant (Iluvien®): in diabetic macular oedema. (2013) pubmed
- Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review. (2019) pubmed
- Intravitreal Fluocinolone Acetonide Implant (ILUVIEN(®)) for the Treatment of Retinal Conditions. A Review of Clinical Studies. (2023) pubmed
- Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review. (2018) pubmed
- PMID:31876997 (2019) pubmed
- Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN(®)) and Follow-Up Considerations/Recommendations. (2020) pubmed
- Fluocinolone acetonide implant (Iluvien®) for macular edema associated with retinitis pigmentosa: A case report. (2023) pubmed
- Clinical utility of intravitreal fluocinolone acetonide (Iluvien(®)) implant in the management of patients with chronic diabetic macular edema: a review of the current literature. (2017) pubmed
- Preventing relapse in non-infectious uveitis affecting the posterior segment of the eye - evaluating the 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN(®)). (2020) pubmed